img

Global Wilson`s Disease Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Wilson`s Disease Treatment Market Research Report 2024

Wilson’s disease is a genetic disorder caused by the loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which results in accumulation of free copper in the bloodstream that results in damage of liver, brain, and other organs. As Wilson’s disease is hard to differentiate from other serious hepatic or neurologic condition that result in less number of patient to be diagnosed than the actual prevalence of Wilson’s disease. Wilson’s disease is characterized by the degree of accumulation of free copper in liver and the brain. Whereas, the patients that suffer from Wilson’s disease can either be asymptomatic or can have one or more clinical symptoms which can vary in type and its severity that include liver disease, neurologic manifestations and psychiatric disturbances. The symptoms for Wilson’s disease may include abdominal pain, lack of appetite, fatigue, jaundice, problems with speech, swallowing or physical coordination and uncontrolled movements or muscle stiffness.
According to MRAResearch’s new survey, global Wilson`s Disease Treatment market is projected to reach US$ 785.1 million in 2033, increasing from US$ 612.3 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Wilson`s Disease Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Wilson`s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Valeant Pharmaceuticals International. Inc
Tsumura & Co
Merck & Co
VHB Life Science Inc.
Teva Pharmaceuticals USA, Inc
Wilson’s Therapeutics AB
Noble Pharma Co., Ltd
Kadmon Holding, Inc
ANI Pharmaceuticals, Inc
APOTEX, Bausch Health Companies Inc
Breckenridge Pharmaceutical, Inc
Dr. Reddy's Laboratories Ltd
Lupin Limited
NAVINTA LLC
Pfizer Inc.
Vivet Therapeutics
Segment by Type
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others

Segment by Application


Government
Hospitals
Medical Practitioners
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Wilson`s Disease Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wilson`s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 D-Penicillamine
1.2.3 Trientine
1.2.4 Zinc
1.2.5 Tetrathiomolybdate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Wilson`s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Government
1.3.3 Hospitals
1.3.4 Medical Practitioners
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Wilson`s Disease Treatment Market Perspective (2018-2033)
2.2 Wilson`s Disease Treatment Growth Trends by Region
2.2.1 Global Wilson`s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Wilson`s Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Wilson`s Disease Treatment Forecasted Market Size by Region (2024-2033)
2.3 Wilson`s Disease Treatment Market Dynamics
2.3.1 Wilson`s Disease Treatment Industry Trends
2.3.2 Wilson`s Disease Treatment Market Drivers
2.3.3 Wilson`s Disease Treatment Market Challenges
2.3.4 Wilson`s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Wilson`s Disease Treatment Players by Revenue
3.1.1 Global Top Wilson`s Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Wilson`s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Wilson`s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Wilson`s Disease Treatment Revenue
3.4 Global Wilson`s Disease Treatment Market Concentration Ratio
3.4.1 Global Wilson`s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wilson`s Disease Treatment Revenue in 2022
3.5 Wilson`s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Wilson`s Disease Treatment Product Solution and Service
3.7 Date of Enter into Wilson`s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Wilson`s Disease Treatment Breakdown Data by Type
4.1 Global Wilson`s Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Wilson`s Disease Treatment Forecasted Market Size by Type (2024-2033)
5 Wilson`s Disease Treatment Breakdown Data by Application
5.1 Global Wilson`s Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Wilson`s Disease Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Wilson`s Disease Treatment Market Size (2018-2033)
6.2 North America Wilson`s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Wilson`s Disease Treatment Market Size by Country (2018-2023)
6.4 North America Wilson`s Disease Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Wilson`s Disease Treatment Market Size (2018-2033)
7.2 Europe Wilson`s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Wilson`s Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Wilson`s Disease Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Wilson`s Disease Treatment Market Size (2018-2033)
8.2 Asia-Pacific Wilson`s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Wilson`s Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Wilson`s Disease Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Wilson`s Disease Treatment Market Size (2018-2033)
9.2 Latin America Wilson`s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Wilson`s Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Wilson`s Disease Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Wilson`s Disease Treatment Market Size (2018-2033)
10.2 Middle East & Africa Wilson`s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Wilson`s Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Wilson`s Disease Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Valeant Pharmaceuticals International. Inc
11.1.1 Valeant Pharmaceuticals International. Inc Company Detail
11.1.2 Valeant Pharmaceuticals International. Inc Business Overview
11.1.3 Valeant Pharmaceuticals International. Inc Wilson`s Disease Treatment Introduction
11.1.4 Valeant Pharmaceuticals International. Inc Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.1.5 Valeant Pharmaceuticals International. Inc Recent Development
11.2 Tsumura & Co
11.2.1 Tsumura & Co Company Detail
11.2.2 Tsumura & Co Business Overview
11.2.3 Tsumura & Co Wilson`s Disease Treatment Introduction
11.2.4 Tsumura & Co Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.2.5 Tsumura & Co Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Detail
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Wilson`s Disease Treatment Introduction
11.3.4 Merck & Co Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.3.5 Merck & Co Recent Development
11.4 VHB Life Science Inc.
11.4.1 VHB Life Science Inc. Company Detail
11.4.2 VHB Life Science Inc. Business Overview
11.4.3 VHB Life Science Inc. Wilson`s Disease Treatment Introduction
11.4.4 VHB Life Science Inc. Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.4.5 VHB Life Science Inc. Recent Development
11.5 Teva Pharmaceuticals USA, Inc
11.5.1 Teva Pharmaceuticals USA, Inc Company Detail
11.5.2 Teva Pharmaceuticals USA, Inc Business Overview
11.5.3 Teva Pharmaceuticals USA, Inc Wilson`s Disease Treatment Introduction
11.5.4 Teva Pharmaceuticals USA, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals USA, Inc Recent Development
11.6 Wilson’s Therapeutics AB
11.6.1 Wilson’s Therapeutics AB Company Detail
11.6.2 Wilson’s Therapeutics AB Business Overview
11.6.3 Wilson’s Therapeutics AB Wilson`s Disease Treatment Introduction
11.6.4 Wilson’s Therapeutics AB Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.6.5 Wilson’s Therapeutics AB Recent Development
11.7 Noble Pharma Co., Ltd
11.7.1 Noble Pharma Co., Ltd Company Detail
11.7.2 Noble Pharma Co., Ltd Business Overview
11.7.3 Noble Pharma Co., Ltd Wilson`s Disease Treatment Introduction
11.7.4 Noble Pharma Co., Ltd Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.7.5 Noble Pharma Co., Ltd Recent Development
11.8 Kadmon Holding, Inc
11.8.1 Kadmon Holding, Inc Company Detail
11.8.2 Kadmon Holding, Inc Business Overview
11.8.3 Kadmon Holding, Inc Wilson`s Disease Treatment Introduction
11.8.4 Kadmon Holding, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.8.5 Kadmon Holding, Inc Recent Development
11.9 ANI Pharmaceuticals, Inc
11.9.1 ANI Pharmaceuticals, Inc Company Detail
11.9.2 ANI Pharmaceuticals, Inc Business Overview
11.9.3 ANI Pharmaceuticals, Inc Wilson`s Disease Treatment Introduction
11.9.4 ANI Pharmaceuticals, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.9.5 ANI Pharmaceuticals, Inc Recent Development
11.10 APOTEX, Bausch Health Companies Inc
11.10.1 APOTEX, Bausch Health Companies Inc Company Detail
11.10.2 APOTEX, Bausch Health Companies Inc Business Overview
11.10.3 APOTEX, Bausch Health Companies Inc Wilson`s Disease Treatment Introduction
11.10.4 APOTEX, Bausch Health Companies Inc Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.10.5 APOTEX, Bausch Health Companies Inc Recent Development
11.11 Breckenridge Pharmaceutical, Inc
11.11.1 Breckenridge Pharmaceutical, Inc Company Detail
11.11.2 Breckenridge Pharmaceutical, Inc Business Overview
11.11.3 Breckenridge Pharmaceutical, Inc Wilson`s Disease Treatment Introduction
11.11.4 Breckenridge Pharmaceutical, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.11.5 Breckenridge Pharmaceutical, Inc Recent Development
11.12 Dr. Reddy's Laboratories Ltd
11.12.1 Dr. Reddy's Laboratories Ltd Company Detail
11.12.2 Dr. Reddy's Laboratories Ltd Business Overview
11.12.3 Dr. Reddy's Laboratories Ltd Wilson`s Disease Treatment Introduction
11.12.4 Dr. Reddy's Laboratories Ltd Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.12.5 Dr. Reddy's Laboratories Ltd Recent Development
11.13 Lupin Limited
11.13.1 Lupin Limited Company Detail
11.13.2 Lupin Limited Business Overview
11.13.3 Lupin Limited Wilson`s Disease Treatment Introduction
11.13.4 Lupin Limited Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.13.5 Lupin Limited Recent Development
11.14 NAVINTA LLC
11.14.1 NAVINTA LLC Company Detail
11.14.2 NAVINTA LLC Business Overview
11.14.3 NAVINTA LLC Wilson`s Disease Treatment Introduction
11.14.4 NAVINTA LLC Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.14.5 NAVINTA LLC Recent Development
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Detail
11.15.2 Pfizer Inc. Business Overview
11.15.3 Pfizer Inc. Wilson`s Disease Treatment Introduction
11.15.4 Pfizer Inc. Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.15.5 Pfizer Inc. Recent Development
11.16 Vivet Therapeutics
11.16.1 Vivet Therapeutics Company Detail
11.16.2 Vivet Therapeutics Business Overview
11.16.3 Vivet Therapeutics Wilson`s Disease Treatment Introduction
11.16.4 Vivet Therapeutics Revenue in Wilson`s Disease Treatment Business (2018-2023)
11.16.5 Vivet Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Wilson`s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of D-Penicillamine
Table 3. Key Players of Trientine
Table 4. Key Players of Zinc
Table 5. Key Players of Tetrathiomolybdate
Table 6. Key Players of Others
Table 7. Global Wilson`s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Wilson`s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Wilson`s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Wilson`s Disease Treatment Market Share by Region (2018-2023)
Table 11. Global Wilson`s Disease Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Wilson`s Disease Treatment Market Share by Region (2024-2033)
Table 13. Wilson`s Disease Treatment Market Trends
Table 14. Wilson`s Disease Treatment Market Drivers
Table 15. Wilson`s Disease Treatment Market Challenges
Table 16. Wilson`s Disease Treatment Market Restraints
Table 17. Global Wilson`s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Wilson`s Disease Treatment Market Share by Players (2018-2023)
Table 19. Global Top Wilson`s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson`s Disease Treatment as of 2022)
Table 20. Ranking of Global Top Wilson`s Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Wilson`s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Wilson`s Disease Treatment Product Solution and Service
Table 24. Date of Enter into Wilson`s Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Wilson`s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Wilson`s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Wilson`s Disease Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Wilson`s Disease Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Wilson`s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Wilson`s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Wilson`s Disease Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Wilson`s Disease Treatment Revenue Market Share by Application (2024-2033)
Table 34. North America Wilson`s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Wilson`s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Wilson`s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Wilson`s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Wilson`s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Wilson`s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Wilson`s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Wilson`s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Wilson`s Disease Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Wilson`s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Wilson`s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Wilson`s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Wilson`s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Wilson`s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Wilson`s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 49. Valeant Pharmaceuticals International. Inc Company Detail
Table 50. Valeant Pharmaceuticals International. Inc Business Overview
Table 51. Valeant Pharmaceuticals International. Inc Wilson`s Disease Treatment Product
Table 52. Valeant Pharmaceuticals International. Inc Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 53. Valeant Pharmaceuticals International. Inc Recent Development
Table 54. Tsumura & Co Company Detail
Table 55. Tsumura & Co Business Overview
Table 56. Tsumura & Co Wilson`s Disease Treatment Product
Table 57. Tsumura & Co Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 58. Tsumura & Co Recent Development
Table 59. Merck & Co Company Detail
Table 60. Merck & Co Business Overview
Table 61. Merck & Co Wilson`s Disease Treatment Product
Table 62. Merck & Co Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 63. Merck & Co Recent Development
Table 64. VHB Life Science Inc. Company Detail
Table 65. VHB Life Science Inc. Business Overview
Table 66. VHB Life Science Inc. Wilson`s Disease Treatment Product
Table 67. VHB Life Science Inc. Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 68. VHB Life Science Inc. Recent Development
Table 69. Teva Pharmaceuticals USA, Inc Company Detail
Table 70. Teva Pharmaceuticals USA, Inc Business Overview
Table 71. Teva Pharmaceuticals USA, Inc Wilson`s Disease Treatment Product
Table 72. Teva Pharmaceuticals USA, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 73. Teva Pharmaceuticals USA, Inc Recent Development
Table 74. Wilson’s Therapeutics AB Company Detail
Table 75. Wilson’s Therapeutics AB Business Overview
Table 76. Wilson’s Therapeutics AB Wilson`s Disease Treatment Product
Table 77. Wilson’s Therapeutics AB Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 78. Wilson’s Therapeutics AB Recent Development
Table 79. Noble Pharma Co., Ltd Company Detail
Table 80. Noble Pharma Co., Ltd Business Overview
Table 81. Noble Pharma Co., Ltd Wilson`s Disease Treatment Product
Table 82. Noble Pharma Co., Ltd Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 83. Noble Pharma Co., Ltd Recent Development
Table 84. Kadmon Holding, Inc Company Detail
Table 85. Kadmon Holding, Inc Business Overview
Table 86. Kadmon Holding, Inc Wilson`s Disease Treatment Product
Table 87. Kadmon Holding, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 88. Kadmon Holding, Inc Recent Development
Table 89. ANI Pharmaceuticals, Inc Company Detail
Table 90. ANI Pharmaceuticals, Inc Business Overview
Table 91. ANI Pharmaceuticals, Inc Wilson`s Disease Treatment Product
Table 92. ANI Pharmaceuticals, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 93. ANI Pharmaceuticals, Inc Recent Development
Table 94. APOTEX, Bausch Health Companies Inc Company Detail
Table 95. APOTEX, Bausch Health Companies Inc Business Overview
Table 96. APOTEX, Bausch Health Companies Inc Wilson`s Disease Treatment Product
Table 97. APOTEX, Bausch Health Companies Inc Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 98. APOTEX, Bausch Health Companies Inc Recent Development
Table 99. Breckenridge Pharmaceutical, Inc Company Detail
Table 100. Breckenridge Pharmaceutical, Inc Business Overview
Table 101. Breckenridge Pharmaceutical, Inc Wilson`s Disease Treatment Product
Table 102. Breckenridge Pharmaceutical, Inc Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 103. Breckenridge Pharmaceutical, Inc Recent Development
Table 104. Dr. Reddy's Laboratories Ltd Company Detail
Table 105. Dr. Reddy's Laboratories Ltd Business Overview
Table 106. Dr. Reddy's Laboratories Ltd Wilson`s Disease Treatment Product
Table 107. Dr. Reddy's Laboratories Ltd Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 108. Dr. Reddy's Laboratories Ltd Recent Development
Table 109. Lupin Limited Company Detail
Table 110. Lupin Limited Business Overview
Table 111. Lupin Limited Wilson`s Disease Treatment Product
Table 112. Lupin Limited Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 113. Lupin Limited Recent Development
Table 114. NAVINTA LLC Company Detail
Table 115. NAVINTA LLC Business Overview
Table 116. NAVINTA LLC Wilson`s Disease Treatment Product
Table 117. NAVINTA LLC Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 118. NAVINTA LLC Recent Development
Table 119. Pfizer Inc. Company Detail
Table 120. Pfizer Inc. Business Overview
Table 121. Pfizer Inc. Wilson`s Disease Treatment Product
Table 122. Pfizer Inc. Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 123. Pfizer Inc. Recent Development
Table 124. Vivet Therapeutics Company Detail
Table 125. Vivet Therapeutics Business Overview
Table 126. Vivet Therapeutics Wilson`s Disease Treatment Product
Table 127. Vivet Therapeutics Revenue in Wilson`s Disease Treatment Business (2018-2023) & (US$ Million)
Table 128. Vivet Therapeutics Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Wilson`s Disease Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Wilson`s Disease Treatment Market Share by Type: 2022 VS 2033
Figure 3. D-Penicillamine Features
Figure 4. Trientine Features
Figure 5. Zinc Features
Figure 6. Tetrathiomolybdate Features
Figure 7. Others Features
Figure 8. Global Wilson`s Disease Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Wilson`s Disease Treatment Market Share by Application: 2022 VS 2033
Figure 10. Government Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Medical Practitioners Case Studies
Figure 13. Wilson`s Disease Treatment Report Years Considered
Figure 14. Global Wilson`s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Wilson`s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Wilson`s Disease Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Wilson`s Disease Treatment Market Share by Players in 2022
Figure 18. Global Top Wilson`s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson`s Disease Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Wilson`s Disease Treatment Revenue in 2022
Figure 20. North America Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Wilson`s Disease Treatment Market Share by Country (2018-2033)
Figure 22. United States Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Wilson`s Disease Treatment Market Share by Country (2018-2033)
Figure 26. Germany Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Wilson`s Disease Treatment Market Share by Region (2018-2033)
Figure 34. China Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Wilson`s Disease Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Wilson`s Disease Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Wilson`s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Valeant Pharmaceuticals International. Inc Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 49. Tsumura & Co Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 50. Merck & Co Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 51. VHB Life Science Inc. Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 52. Teva Pharmaceuticals USA, Inc Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 53. Wilson’s Therapeutics AB Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 54. Noble Pharma Co., Ltd Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 55. Kadmon Holding, Inc Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 56. ANI Pharmaceuticals, Inc Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 57. APOTEX, Bausch Health Companies Inc Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 58. Breckenridge Pharmaceutical, Inc Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 59. Dr. Reddy's Laboratories Ltd Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 60. Lupin Limited Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 61. NAVINTA LLC Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 62. Pfizer Inc. Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 63. Vivet Therapeutics Revenue Growth Rate in Wilson`s Disease Treatment Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed